Author:
Weiss Lars G.,Clyne Naomi,Fihlho Jose Divino,Frisenette‐Fich Carsten,Kurkus Jan,Svensson Birgitta
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Reference20 articles.
1. Bommer J, Alexiou C, Muller‐Buhel U, Eifert J, Ritz E. Recombinant human erythropoietin therapy in haemodialysis patients—dose determination and clinical experience. Nephrol Dial Transplant1987; 2: 238–242
2. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ1990; 300: 573–578
3. Bommer J, Kugel M, Schoeppe W et al. Dose‐related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end‐stage renal disease. Contrib Nephrol1988; 66: 85–93
4. Eschbach JW, Abdulhadi MH, Browne JK et al. Recombinant human erythropoietin in anemia patients with end‐stage renal disease. Ann Intern Med1989; 111: 992–1000
5. Bommer J, Ritz E, Weinreich T, Bommer G, Ziegler T. Subcutaneous erythropoietin (letter) Lancet1988; 2: 406
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献